Founded by three of the world’s leading authorities in neuroscience, medicine and computer science, Mindstrong Health is redefining behavioral healthcare by redefining how care providers will diagnose and manage brain disorders.
Mindstrong’s technology will – for the first time - give patients and providers a seamless and instantaneous method to objectively and continuously measure mood, cognition, and behavior in the home and work environment, delivering insights not possible with traditional clinical, neuropsychological, and imaging techniques.
Mindstrong builds on one of the founder’s digital biomarker platform developed over years of extensive R&D.
Our Values : Science That Makes a Difference.
Measuring Success: Changing Minds and Fixing brains.
Board of Directors
Mindstrong's Board of Directors bring deep experience working at the intersection of academia and industry.
Rick Klausner, MD
Co-Founder and Executive Chairman, Mindstrong Health
Partner, Optum Ventures
Tom Insel, MD
Co-Founder and President, Mindstrong Health
Robert Epstein, MD
CEO, Epstein Health
Paul Dagum, MD PHD
Founder and Chief Executive Officer, Mindstrong Health
Scientific Advisory Board
Mindstrong's Scientific Advisory Board provides leading scientific oversight and guidance.
Sir Philip Campbell, PhD
part of Nature Publishing Group
Ian Gotlib, PhD
Professor and Chair, Psychology,
Sophia Vinogradov, MD
Professor and Head, Department of Psychiatry,
University of Minnesota
Amit Etkin, MD, PhD
Associate Professor of Psychiatry andBehavioral Science,
Michael Frumkin, MS
Director, Google Accelerated Science;
Ethical-Legal-Social Implications (ELSI) Board
Mindstrong's ELSI Board ensures that digital biomarkers for the diagnosis and treatment of mental health conditions earns and maintains public trust.
President & CEO, Mental Health America
Director, One Mind
Nev Jones, PhD
Director of Research, Felton Institute
Nicole Martinez, PhD, JD
Postdoctoral Fellow, Stanford Bioethics
Sharon Terry, MA
President & CEO, Genetic Alliance
Katherine Switz, MBA
Founder & Executive Director, The Stability Network
Executive Director, Living Assistance Fund
Mindstrong’s investors have launched some of the most transformative biotechnology and healthcare companies in neuropsychiatry and neurodegeneration.
Mindstrong has developed and patented a biomarker panel that measures brain function from interaction patterns captured passively and continuously from human-computer interfaces found in ubiquitous mobile technology.